AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
Go back to AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS| Amgen Inc (NASDAQ: AMGN) | Delayed: 344.72 +7.12 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $337.60 | 52 Week High | $176.85 | |||
| Open | $337.65 | 52 Week Low | $133.64 | |||
| Day High | $345.11 | P/E | 51.92 | |||
| Day Low | $337.60 | EPS | $6.64 | |||
| Volume | 2,520,731 | |||||

